These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
116 related articles for article (PubMed ID: 24163898)
1. Atrial fibrillation and stroke: risk stratification and new anticoagulants. Jazra C; Khoury M J Med Liban; 2013; 61(2):109-12. PubMed ID: 24163898 [No Abstract] [Full Text] [Related]
2. Stroke risk stratification in atrial fibrillation: something to EXAMINE more closely. Watson T; Kakar P; Lip GY Int J Clin Pract; 2007 Jan; 61(1):6-9. PubMed ID: 17229172 [No Abstract] [Full Text] [Related]
3. Anticoagulation for stroke prevention in elderly patients with non-valvular atrial fibrillation: what are the obstacles? Wong CW Hong Kong Med J; 2016 Dec; 22(6):608-15. PubMed ID: 27920399 [TBL] [Abstract][Full Text] [Related]
4. Stroke prevention in nonvalvular atrial fibrillation: update on target-specific oral anticoagulants. Patrick C; Clarke R J Contin Educ Nurs; 2015 Apr; 46(4):152-4. PubMed ID: 25856447 [TBL] [Abstract][Full Text] [Related]
5. Risk factors and stroke risk stratification for atrial fibrillation: limitations and new possibilities. Lip GY Am Heart J; 2008 Jul; 156(1):1-3. PubMed ID: 18585489 [No Abstract] [Full Text] [Related]
6. Using the CHA(2)DS(2)-VASc score for stroke risk stratification in atrial fibrillation: a clinical perspective. Lip GY Expert Rev Cardiovasc Ther; 2013 Mar; 11(3):259-62. PubMed ID: 23469902 [No Abstract] [Full Text] [Related]
7. Stroke prevention in atrial fibrillation. Waldo AL JAMA; 2003 Aug; 290(8):1093-5. PubMed ID: 12941684 [No Abstract] [Full Text] [Related]
8. On the Way to a Better Use of Anticoagulants in Nonvalvular Atrial Fibrillation. Proposed Amendment to the Therapeutic Positioning Report UT/V4/23122013. Roldán I; Marín F; ; ; ; ; ; ; Rev Esp Cardiol (Engl Ed); 2016 Jun; 69(6):551-3. PubMed ID: 27162063 [No Abstract] [Full Text] [Related]
17. Risk stratification and stroke prevention therapy care gaps in Canadian atrial fibrillation patients (from the Co-ordinated National Network to Engage Physicians in the Care and Treatment of Patients With Atrial Fibrillation chart audit). Patel AD; Tan MK; Angaran P; Bell AD; Berall M; Bucci C; Demchuk AM; Essebag V; Goldin L; Green MS; Gregoire JC; Gross PL; Heilbron B; Lin PJ; Ramanathan K; Skanes A; Wheeler BH; Goodman SG Am J Cardiol; 2015 Mar; 115(5):641-6. PubMed ID: 25727083 [TBL] [Abstract][Full Text] [Related]
18. Stroke prevention in atrial fibrillation: current anticoagulation management and future directions. Fitzgerald BT; Cohn SL; Klein AL Cleve Clin J Med; 2005 Apr; 72 Suppl 1():S24-30. PubMed ID: 15853176 [TBL] [Abstract][Full Text] [Related]
19. Pro: 'Warfarin should be the drug of choice for thromboprophylaxis in elderly patients with atrial fibrillation'. Why warfarin should really be the drug of choice for stroke prevention in elderly patients with atrial fibrillation. Mant JW Thromb Haemost; 2008 Jul; 100(1):14-5. PubMed ID: 18612531 [No Abstract] [Full Text] [Related]